DarrylAlanOutlawJr.MD
Internal Medicine • Birmingham, ALHematology/Oncology
Fellow, Hematology-Oncology
Dr. Outlaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
625 19th St S
Birmingham, AL 35233Phone+1 205-934-2490
Education & Training
University of Alabama Medical CenterResidency, Internal Medicine, 2015 - 2018
University of Alabama School of MedicineClass of 2015
Certifications & Licensure
AL State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer Start of enrollment: 2021 Jun 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 19 citationsPatient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies.Smith Giri, Mustafa Al-Obaidi, Christian Harmon, Deanna Clark, Clare Ubersax
Journal of the American Geriatrics Society. 2023-01-01 - 15 citationsThe Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade.Darryl Outlaw, Maya Abdallah, Luiz A Gil-Jr, Smith Giri, Tina Hsu
Seminars in Radiation Oncology. 2022-04-01 - 8 citationsIs the lack of evidence in older adults with cancer compromising safetyDarryl Alan Outlaw, Grant R. Williams
Expert Opinion on Drug Safety. 2020-08-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
